Effects of quinine, quinidine, and chloroquine on α9α10 nicotinic cholinergic receptors

Molecular Pharmacology

Volumn 68, Issue 3, 2005, Pages 822-829

  Ballestero, Jimena A ^a   Plazas, Paola V ^a   Kracun, Sebastian ^c   Gómez Casati, María E ^a   Taranda, Julián ^a   Rothlin, Carla V ^a,d   Katz, Eleonora ^b   Millar, Neil S ^c   Elgoyhen, A Belén ^a  

^a INSTITUTO DE INVESTIGACIONES EN INGENIERÍA GENÉTICA Y BIOLOGÍA MOLECULAR   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ANTIMALARIAL AGENT; CHLOROQUINE; NICOTINIC RECEPTOR; QUINIDINE; QUININE SULFATE; RECEPTOR SUBUNIT;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CHOLINERGIC RECEPTOR BLOCKING; COCHLEA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG COMPETITION; DRUG EFFECT; DRUG POTENCY; DRUG RECEPTOR BINDING; EVOKED RESPONSE; HAIR CELL; HUMAN; HUMAN CELL; IC 50; MOUSE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; XENOPUS LAEVIS;

ANIMALS; ANTIMALARIALS; CHLOROQUINE; HAIR CELLS, INNER; QUINIDINE; QUININE; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; RECOMBINANT PROTEINS; XENOPUS LAEVIS;

EID: 23944497896     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.105.014431     Document Type: Article

References (39)

1. Arunlakshana O and Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48-58.
2. Baker ER, Zwart R, Sher E, and Millar NS (2004) Pharmacological properties of α9α10 nicotinic acetylcholine receptors revealed by heterologous expression of subunit chimeras. Mol Pharmacol 65:453-460.
3. Barrenas ML and Holgers KM (2000) Ototoxic interaction between noise and pheomelanin: distortion product otoacoustic emissions after acoustical trauma in chloroquine-treated red, black and albino guinea pigs. Audiology 39:238-246.
4. Berninger E, Karlsson K, and Alvan G (1998) Quinine reduces the dynamic range of the human auditory system. Acta Otolaryngol 118:46-51.
5. Cheng Y and Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
6. Daigneault EA, Pruett JR, and Brown RD (1970) Influence of ototoxic drugs on acetylcholine-induced depression of the cochlear N1 potential. Toxicol Appl Pharmacol 17:223-230.
7. Eggermont JJ and Kenmochi M (1998) Salicylate and quinine selectively increase spontaneous firing rates in secondary auditory cortex. Hear Res 117:149-160.
8. Elgoyhen AB, Johnson DS, Boulter J, Vetter DE, and Heinemann S (1994) α9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell 79:705-715.
9. Elgoyhen AB, Vetter D, Katz E, Rothlin C, Heinemann S, and Boulter J (2001) α10: A determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. Proc Nat Acad Sci USA 98:3501-3506.
10. Franke U, Proksch B, Muller M, Risler M, and Ehninger G (1983) Drug monitoring of quinine by HPLC in cerebral malaria with acute renal failure treated by haemofiltration. Eur J Clin Pharmacol 15:345-350.
11. Fuchs P (1996) Synaptic transmission at vertebrate hair cells. Curr Opin Neurobiol 6:514-519.
12. Fukudome T, Ohno K, Brengman JM, and Engel AG (1998) Quinidine normalizes the open duration of slow-channel mutants of the acetylcholine receptor. Neuroreport 9:1907-1911.
13. Guinan JJ (1996) Physiology of olivocochlear efferents, in The Cochlea (Dallos P, Popper AN, and Fay RR eds) pp 435-502, Springer-Verlag, New York.
14. Jarboe JK and Hallworth R (1999) The effect of quinine on outer hair cell shape, compliance and force. Hear Res 132:43-50.
15. Jung TT, Rhee CK, Lee CS, Park YS, and Choi DC (1993) Ototoxicity of salicylate, nonsteroidal antiinflammatory drugs and quinine. Otolaryngol Clin North Am 26:791-810.
16. Karlin A (2002) Ion channel structure: emerging structure of the nicotinic acetylcholine receptors. Nat Rev Neurosci 3:102-114.
17. Katz E, Elgoyhen AB, Gomez-Casati ME, Knipper M, Vetter DE, Fuchs PA, and Glowatzki E (2004) Developmental regulation of nicotinic synapses on cochlear inner hair cells. J Neurosci 24:7814-7820.
18. Katz E, Verbitsky M, Rothlin C, Vetter D, Heinemann S, and Elgoyhen A (2000) High calcium permeability and calcium block of the α9 nicotinic acetylcholine receptor. Hear Res 141:117-128.
19. Kessler K, Lowenthal D, Warner H, Gibson T, Briggs W, and Reidenberg M (1974) Quinidine elimination in patients with congestive heart failure or poor renal function. N Engl J Med 290:706-709.
20. Kros CJ, Ruppersberg JP, and Rusch A (1998) Expression of a potassium current in inner hair cells during development of hearing in mice. Nature (Lond) 394:281-284.
21. Leff P and Dougall IG (1993) Further concerns over Cheng-Prusoff analysis. Trends Pharmacol Sci 14:110-112.
22. + channel determined by construction of multimeric cDNAs. Neuron 9:861-871.
23. Lin X, Chen S, and Tee D (1998) Effects of quinine on the excitability and voltage-dependent currents of isolated spiral ganglion neurons in culture. J Neurophysiol 79:2503-2512.
24. + current in isolated outer hair cells of the guinea pig. Hear Res 88:36-46.
25. Lustig LR, Peng H, Hiel H, Yamamoto T, and Fuchs P (2001) Molecular cloning and mapping of the human nicotinic acetylcholine receptor α10 (CHRNA10). Genomics 73:272-283.
26. McFadden D and Pasanen E (1994) Otoacustic emissions and quinine sulfate. J Acoust Soc Am 95:3460-3474.
27. Neubig RR, Spedding M, Kenakin T, and Christopoulos A (2003) International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology. Pharmacol Rev 55:597-606.
28. Patuzzi RB and Thompson ML (1991) Cochlear efferent neurons and protection against acoustic trauma: Protection of outer hair cell receptor current and interanimal variability. Hear Res 54:45-58.
29. Plazas PV, De Rosa MJ, Gomez-Casati ME, Verbitsky M, Weisstaub N, Katz E, Bouzat C, and Elgoyhen AB (2005) Key roles of hydrophobic rings of TM2 in gating of the alpha9alpha10 nicotinic cholinergic receptor. Br J Pharmacol, in press.
30. Puel JL, Bobbin RP, and Fallon M (1990) Salicylate, mefenamate, meclofenamate and quinine on cochlear potentials. Otolaryngol Head Neck Surg 102:66-73.
31. Rothlin CV, Katz E, Verbitsky M, Vetter D, Heinemann S, and Elgoyhen AB (2000) Block of the α9 nicotinic receptor by ototoxic aminoglycosides. Neuropharmacology 39:2525-2532.
32. Sgard F, Charpentier E, Bertrand S, Walker N, Caput D, Graham D, Bertrand D, and Besnard F (2002) A novel human nicotinic receptor subunit, α10, that confers functionality to the α9-subunit. Mol Pharmacol 61:150-159.
33. Sieb JP, Milone M, and Engel AG (1996) Effects of the quinoline derivatives quinine, quinidine and chloroquine on neuromuscular transmission. Brain Res 712:179-189.
34. Tracy J and Webster L Jr (2001) Chemotherapy of parasitic infections, in Goodman & Gilman's The Pharmacological Basis of Therapeutics (Hardman LGG ed) pp 1059-1120, McGraw-Hill, New York.
35. Weisstaub N, Vetter D, Elgoyhen A, and Katz E (2002) The alpha9/alpha10 nicotinic acetylcholine receptor is permeable to and is modulated by divalent cations. Hear Res 167:122-135.
36. Worner M, Gensler M, Bahn B, and Schreier P (1989) Use of solid phase extraction for rapid sample preparation in the determination of food constituents. I. Quinine in beverages. Z Lebensm Unters Forsch 189:422-425.
37. Yamamoto T, Kakehata S, Yamada T, Saito T, Saito H, and Akaike N (1997) Effects of potassium channel blockers on the acetylcholine-induced currents in dissociated outer hair cells of guinea pig cochlea. Neurosci Lett 236:79-82.
38. Zajtchuk JT, Mihail R, Jewell JS, Dunne MJ, and Chadwick SG (1984) Electronystagmographic findings in long-term low-dose quinine ingestion. A preliminary report. Arch Otolaryngol 110:788-791.
39. Zheng J, Ren T, Parthasarathi A, and Nuttall AL (2001) Quinine-induced alterations of electrically evoked otoacoustic emissions and cochlear potentials in guinea pigs. Hear Res 154:124-134.